Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  nausea and vomiting
Trial Type:  Supportive care
Results 1-13 of 13 for your search:
Start Over
Antiemetic Therapy with or without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Receiving Highly Emetogenic Chemotherapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221301, NCI-2014-00446, NCT02116530
Dexmedetomidine Hydrochloride in Reducing Pain in Patients Undergoing Thoracic Surgery
Status: Active
Phase: Phase III
Type: Supportive care
Age: 21 and over
Trial IDs: 13-163, NCI-2013-02150, NCT01973452
Ropivacaine Hydrochloride via Paravertebral Blocks before Surgery in Decreasing Pain in Patients with Breast Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 to 100
Trial IDs: J1284, NCI-2014-01365, 311945, NA_00075957, NCT02161705
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Status: Active
Phase: Phase III
Type: Prevention, Supportive care
Age: 17 and under
Trial IDs: 0517-044, NCI-2016-00659, 2014-001783-34, NCT02519842
Ondansetron with or without Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Gliomas
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: Pro00031206, NCI-2013-00520, NCT01450826
Fosaprepitant Dimeglumine, 5HT3 Receptor Antagonists, and Dexamethasone in Reducing Nausea and Vomiting in Patients with Germ Cell Tumors Undergoing Chemotherapy with Cisplatin
Status: Active
Phase: Phase II
Type: Supportive care
Age: 15 and over
Trial IDs: QL12-153, NCI-2013-00278, 1211010041, 1211010041R001, HOG QL12-153, NCT01736917
Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients with Sarcoma Receiving Chemotherapy
Status: Not yet active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 to 65
Trial IDs: 2015-0587, NCI-2016-00801, NCT02732015
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Status: Temporarily closed
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: GOG-0272, NCI-2011-02660, CDR0000692516, NCT01275664
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients with Breast Cancer Undergoing Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 1B-11-5, NCI-2012-01170, HS-11-00443, NCT01649258
Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients with Newly Diagnosed Acute Leukemia Undergoing Chemotherapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: Not specified
Trial IDs: OSU-14182, NCI-2015-00549, 2014C0156, NCT02445378
Omalizumab in Reducing Refractory Type I Hypersensitivity Reactions in Patients with Cancer Receiving Chemotherapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 13-485, NCI-2014-02030, NCT02118987
Neuromuscular Electrical Stimulation of Acupoint P6 in Preventing Nausea and Vomiting after Surgery in Patients Undergoing Breast Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 2015-0170, NCI-2015-01519, NCT02473042
Electronic Patient Symptom Reporting in Reducing Symptom Burden during Hospitalization in Patients with Cancer Receiving Intensive Chemotherapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 to 75
Trial IDs: LCCC 1404, NCI-2015-00404, 14-1043, NCT02574897
Start Over